Company profile for LEBSA

PharmaCompass

LEBSA- Your strategic API source for niche molecules.

Related CompaniesRelated Companies

About

Lebsa is an innovative European laboratory that specializes in the synthesis, manufacture and commercialization of APIs with a focus on niche products. With a track record spanning 70 years, Lebsa has established itself as a reputable player in the global pharmaceutical market, particularly in generic API manufacturing. Headquartered in Barcelona, Spain, Lebsa exports up to 90% of its production. Lebsa's state-of-the-art facilities, located near Barcelona, feature cutting-edge technology, equipment and automated processes. Lebsa has expertise in registering APIs in countries across Europe, Canada, Taiwan, China, Russia, Brazil and Japan.

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Spain
Address
Address
Ctra. de l'Hospitalet, 34 08940 Cornella, Barcelona
Telephone
Telephone
+34 933770051
Twitter
Twitter
Contact Info
Others

Events

Webinars & Exhibitions

cphi-worldwide-milan-70313.png

CPhI Worldwide, Milan

Contact Supplier

Meeting

Digital content read-more

Explore the latest content creation from this company

CORPORATE CONTENT #SupplierSpotlight

    https://www.pharmacompass.com/pdf/party/content/lebsa-party-content-43449.pdf

    https://www.pharmacompass.com/pdf/party/content/lebsa-party-content-41156.pdf

    https://www.pharmacompass.com/pdf/party/content/lebsa-party-content-1633923600.pdf

NEWS #PharmaBuzz

read-more
read-more

https://lebsa.com/blog/lebsa-shareholders-meeting/

PRESS RELEASE
16 Nov 2023

https://lebsa.com/blog/lebsa-selectchemie-innovation-pharmaceutical/

PRESS RELEASE
31 Oct 2023

https://lebsa.com/blog/octenidine-dihydrochloride-api-lebsa-challenge-2023/

PRESS RELEASE
19 May 2023
Renewed Gold EcoVadis Medal Award 2022
Renewed Gold EcoVadis Medal Award 2022

16 Jun 2022

// PRESS RELEASE

https://lebsa.com/blog/new-gold-ecovadis-medal-award/

PRESS RELEASE
16 Jun 2022
What Is Coming Next?
What Is Coming Next?

30 May 2022

// PRESS RELEASE

https://lebsa.com/blog/what-is-coming-next/

PRESS RELEASE
30 May 2022

https://lebsa.com/blog/presenting-the-understanding-lebsa-our-origins-values-and-philosophy/

PRESS RELEASE
20 May 2022

01

Dequalinium Chloride

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

USDMF CEP/COS arrow-down JDMF arrow-down EU-WC NDC KDMF VMF ASMF arrow-down AUDIT
Lebsa Company Banner

02

Amisulpride

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

USDMF CEP/COS arrow-down JDMF EU-WC NDC KDMF VMF ASMF arrow-down AUDIT
Lebsa Company Banner

03

Betahistine Dihydrochloride

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

USDMF CEP/COS arrow-down JDMF EU-WC NDC KDMF arrow-down VMF ASMF arrow-down AUDIT
Lebsa Company Banner

04

Histamine Dihydrochloride

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

USDMF CEP/COS arrow-down JDMF EU-WC NDC KDMF VMF ASMF arrow-down AUDIT
Lebsa Company Banner